R Schiele

Author PubWeight™ 37.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Registry. J Am Coll Cardiol 2001 1.82
2 Differences in treatment and outcome of patients with acute myocardial infarction admitted to hospitals with compared to without departments of cardiology; results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA 1+2) Registries and the Myocardial Infarction Registry (MIR). Eur Heart J 2001 1.69
3 Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J 1999 1.66
4 Primary angioplasty versus no reperfusion therapy in patients with acute myocardial infarction and a pre-hospital delay of > 12-24 hours: results from the pooled data of the maximal individual therapy in acute myocardial infarction (MITRA) registry and the myocardial infarction registry (MIR). J Invasive Cardiol 2001 1.46
5 The 60 Minutes Myocardial Infarction Project. Characteristics on admission and clinical outcome in patients with reinfarction compared to patients with a first infarction. Eur Heart J 1998 1.42
6 Local drug delivery via transvascular injection. J Invasive Cardiol 1999 1.40
7 Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Heart 1999 1.39
8 Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Catheter Cardiovasc Interv 1999 1.39
9 Acute myocardial infarction occurring in versus out of the hospital: patient characteristics and clinical outcome. Maximal Individual TheRapy in Acute Myocardial Infarction (MITRA) Study Group. J Am Coll Cardiol 2000 1.03
10 Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis. Am Heart J 2001 1.00
11 Angina intensity is not different in diabetic and non-diabetic patients with acute myocardial infarction. Z Kardiol 2003 0.92
12 The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J 1997 0.92
13 Incidence, determinants, and clinical course of reinfarction in-hospital after index acute myocardial infarction (results from the pooled data of the maximal individual therapy in acute myocardial infarction [MITRA], and the myocardial infarction registry [MIR]). Am J Cardiol 2001 0.90
14 Intensive treatment of coronary artery disease in diabetic patients in clinical practice: results of the MITRA study. Acta Diabetol 2003 0.89
15 [The prevalence of pain and deformities in the feet of adolescents. Results of a cross-sectional study]. Z Orthop Ihre Grenzgeb 2004 0.88
16 Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice. MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction . Am J Cardiol 2001 0.85
17 Decreasing hospital mortality between 1994 and 1998 in patients with acute myocardial infarction treated with primary angioplasty but not in patients treated with intravenous thrombolysis. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). J Am Coll Cardiol 2000 0.83
18 Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. ALKK Study Group. Am J Cardiol 1997 0.83
19 In-hospital mortality of elderly patients with acute myocardial infarction: data from the MITRA (Maximal Individual Therapy in Acute Myocardial Infarction) registry. Clin Cardiol 2000 0.83
20 [Intravenous thrombolysis in acute myocardial infarct: optimization of the therapeutic strategy by informing the patients and physicians]. Anasthesiol Intensivmed Notfallmed Schmerzther 1992 0.83
21 Comparison of different cardiac markers in monitoring percutaneous coronary interventions with frequent use of stents and gpIIbIIIa-antagonists. Z Kardiol 2003 0.82
22 [Early treatment of acute myocardial infarct: implementation of therapy guidelines in routine clinical practice, MITRA pilot phase]. Z Kardiol 1997 0.81
23 Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies. Am Heart J 2001 0.81
24 [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries]. Z Kardiol 2002 0.80
25 Effect of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the Myocardial Infarction Registry. Am J Cardiol 2001 0.80
26 [Detection of early kidney damage in workers exposed to lead, mercury, and cadmium (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg B 1980 0.80
27 [Mortality of patients who are older than 75 years after ST elevation myocardial infarction in clinical practice]. Dtsch Med Wochenschr 2005 0.80
28 [Diagnosis of bacterial endocarditis in cattle using intra vitam cultured blood samples]. Dtsch Tierarztl Wochenschr 1984 0.80
29 [Acute myocardial infarction in Germany between 1996 and 1998: therapy and intrahospital course. Results of the Myocardial Infarction Registry (MIR) in Germany]. Z Kardiol 1999 0.80
30 [Prevalence of functional pain of the back, the hip and the knee in adolescents. Results of a cross-sectional study]. Dtsch Med Wochenschr 2004 0.80
31 [Use of coronary angiography after acute myocardial infarction in Germany: a comparison of daily clinical practice with international guidelines. MITRA Study]. Z Kardiol 1999 0.79
32 [Metaanalysis for the evaluation of risk factors for carpal tunnel syndrome (CTS) Part I. General factors]. Z Orthop Unfall 2012 0.79
33 [Metaanalysis for the evaluation of risk factors for carpal tunnel syndrome (CTS) Part II. Occupational risk factors]. Z Orthop Unfall 2012 0.79
34 [Comparison of acute myocardial infarct in the old and new lands of unified Germany, 1996-1998. Data of the Myocardial Infarct Register (MIR)]. Dtsch Med Wochenschr 2000 0.79
35 [Adverse side effects of amalgam? An interdisciplinary study]. Dtsch Zahnarztl Z 1991 0.78
36 [Unusual cadmium burden of mothers and their newborn infants in various areas of Bavaria]. Zentralbl Bakteriol Mikrobiol Hyg B 1985 0.78
37 [Feasibility and safety of dobutamine stress echocardiography: experiences with 1,000 studies]. Z Kardiol 1996 0.78
38 [Mercury mobility through DMPS (Dimaval) in persons with and without amalgam fillings]. Zahnarztl Mitt 1989 0.77
39 Prognostic value of non-sustained ventricular tachycardias after acute myocardial infarction in the thrombolytic era: importance of combination with frequent ventricular premature beats. Z Kardiol 2003 0.77
40 [The human placenta's lead level as a parameter of the ecological lead exposure. Its validity in comparison to the lead level in blood, the activity of the delta-aminolevulinic acid dehydratase and the concentration of the free erythrocyte porphyrins of newborns and their mothers (author's transl)]. Zentralbl Bakteriol Orig B 1976 0.77
41 [The prevalence of radiological osteoarthritis in relation to age, gender, birth-year cohort, and ethnic origins]. Z Orthop Unfall 2011 0.77
42 [Current prescription practice of CSE inhibitors at clinic discharge after acute myocardial infarct]. Z Kardiol 2001 0.77
43 [Prehospital delay-not just a question of patient knowledge]. Z Kardiol 2004 0.76
44 [Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial]. Z Kardiol 2002 0.76
45 [Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement]. Dtsch Med Wochenschr 2010 0.75
46 [Study on the normal mercury concentrations of human organs (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg B 1981 0.75
47 [Knee cartilage lesions and occupational load. Results of an arthroscopic study]. Z Orthop Unfall 2010 0.75
48 [Question of embryo toxicity from mercury in amalgam fillings]. Zahnarztl Mitt 1988 0.75
49 [Applicability and limitations of "biological monitoring" in industrial medicine and epidemiology]. Zentralbl Arbeitsmed Arbeitsschutz Prophyl 1978 0.75
50 [The behaviour of some biochemical parameters in physical stress induced by a long-distance march (author's transl)]. Int Arch Occup Environ Health 1978 0.75
51 Impact of early risk stratification on the length of hospitalization in patients with acute Q-wave myocardial infarction. 'The 60-minutes myocardial infarction project'. Cardiology 1998 0.75
52 [Mercury content of the pulp in unfilled and amalgam-filled teeth]. Dtsch Zahnarztl Z 1987 0.75
53 Transfer of patients with acute myocardial infarction for primary or acute angioplasty from hospitals without the facilities to perform angioplasty. Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry and the Myocardial Infarction Registry (MIR). Herz 2000 0.75
54 [Adrenal gland damage caused by carbon disulfide]. Med Klin 1977 0.75
55 [The blood lead level of mothers and their newborns and the amount of lead in the tissue of human placenta in relation to the environment (author's transl)]. Int Arch Occup Environ Health 1976 0.75
56 [Primary dilatation versus thrombolysis in patients with acute myocardial infarct, not included in randomized studies. Results of the MITRA Study. Maximal Individual Optimized Therapy for Acute Myocardial Infarct]. Z Kardiol 1999 0.75
57 Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities? J Invasive Cardiol 1999 0.75
58 [Current use and outcomes of intraaortic balloon counterpulsation in routine cardiology]. Med Klin (Munich) 2000 0.75
59 [Occlusion of the left main stem after transcatheter aortic valve implantation (TAVI)--a rare complication]. Dtsch Med Wochenschr 2013 0.75
60 [Prevalence and distribution of knee cartilage lesions in sportspersons and non-sportspersons: results of a retrospective arthroscopic study]. Sportverletz Sportschaden 2013 0.75
61 [Field study of workers with longterm exposure to calcium cyanamide (author's transl)]. Zentralbl Bakteriol Mikrobiol Hyg B 1981 0.75
62 [The influence of lead upon the tryptophan metabolism (author's transl)]. Klin Wochenschr 1974 0.75
63 [Bilateral atrioventricular valve endocarditis in a cow as metastasis of reticuloperitonitis caused by a foreign body]. Dtsch Tierarztl Wochenschr 1981 0.75
64 Influence of the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-1) trial on the use of thrombolytics in Germany. ALKK Study Group. Arbeitsgemeinschaft der Leitenden Kardiologischen Krankenhausärtze. Am J Cardiol 1997 0.75
65 Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry. Z Kardiol 2003 0.75
66 Acute myocardial infarction with cardiogenic shock on admission: incidence, prognostic implications, and current treatment strategies. Results from "the 60-Minutes Myocardial Infarction Project". ALKK ("Arbeitsgemeinschaft leitender Krankenhauskardiologen") Study Group. Herz 1999 0.75
67 [Is there a link between the mercury release of amalgam fillings and the results of psychological questionnaires?]. Versicherungsmedizin 2009 0.75
68 [Not Available]. Z Kardiol 2002 0.75
69 Primary percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients not included in randomized studies. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am J Cardiol 1999 0.75
70 [Toxic effects on embryos derived from amalgam restorations containing mercury. West German considerations]. Tandlakartidningen 1989 0.75
71 [Clinical experiences in the use of para-immunity inducers in cattle during animal exhibitions]. Dtsch Tierarztl Wochenschr 1995 0.75
72 [Symptomatic pericardial effusion as initial manifestation of gastric signet ring cell carcinoma]. Dtsch Med Wochenschr 2003 0.75
73 Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Clin Cardiol 1999 0.75